Ironwood Pharmaceuticals (IRWD) Cost of Revenue (2013 - 2020)

Ironwood Pharmaceuticals (IRWD) has 7 years of Cost of Revenue data on file, last reported at $897000.0 in Q4 2020.

• For the quarter ending Q4 2020, Cost of Revenue fell 91.86% year-over-year to $897000.0; the trailing twelve-month figure through Dec 2020 stood at $3.1 million (down 86.86% YoY), and the FY2020 full-year result was $3.1 million, down 86.86% from the prior year.
• Cost of Revenue eased to $897000.0 in Q4 2020, from $2.2 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $21.5 million in Q4 2018 to a low of $506000.0 in Q3 2019.
• A 4-year average of $5.6 million and a median of $3.8 million in 2017 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue soared 390.96% in 2018 and plunged 91.86% in 2020, its largest moves.
• Tracing IRWD's Cost of Revenue over 4 years: stood at $9.0 million in 2017, then jumped by 138.9% to $21.5 million in 2018, then plunged by 48.69% to $11.0 million in 2019, then sank by 91.86% to $897000.0 in 2020.
• Business Quant data shows IRWD's Cost of Revenue at $897000.0 in Q4 2020, $2.2 million in Q1 2020, and $11.0 million in Q4 2019.